MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 59 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,243 | +9.8% | 63,754 | +12.3% | 0.01% | +28.6% |
| Q2 2023 | $74,915 | +31.2% | 56,754 | -29.7% | 0.01% | +16.7% |
| Q1 2023 | $57,085 | -9.4% | 80,754 | -3.9% | 0.01% | -25.0% |
| Q4 2022 | $63,000 | -49.6% | 84,000 | -42.1% | 0.01% | -52.9% |
| Q3 2022 | $125,000 | -32.8% | 145,000 | -10.5% | 0.02% | -32.0% |
| Q2 2022 | $186,000 | +615.4% | 162,000 | +589.4% | 0.02% | +733.3% |
| Q1 2022 | $26,000 | -3.7% | 23,500 | +38.2% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |